Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03914599 · ClinicalTrials.gov registry record
Protective Genetic Factors Against Neurological Diseases
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 124
- Enrollment target
NCT03914599 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 124 participants.
The verdict
NCT03914599 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
NIH Precision Medicine Initiative, started in May 2018, will enroll one million people through an online portal. It hopes to identify genetic variants affecting a variety of human phenotypic outcomes. A giant set of data like this may enable an association of genetic variants with a certain phenotype. However, the association is often compromised due to the collection of phenotypic data that is not well controlled or standardized creating "noisy" data. These phenotypic "noises" can be largely eliminated in clinical studies with stringent criteria and standardization of outcome measurements. In this study, by looking mainly at genetic information and nerve conduction speed, we hope to eliminate the extra "noises" in the data set. Eliminating the extra "noises" should allow us to be able to determine if there are genetic differences between neurological disorders and healthy controls, and if these genetic differences can be attributed to the speed of the nerve conduction.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2022-07-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03914599
The ClinicalTrials.gov registry entry for NCT03914599 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03914599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03914599 about?
NCT03914599 is a clinical study titled "Protective Genetic Factors Against Neurological Diseases". NIH Precision Medicine Initiative, started in May 2018, will enroll one million people through an online portal. It hopes to identify genetic variants affecting a variety of human phenotypic outcomes. A giant set of data like this may enable an association of genetic variants with a certain phenotyp...
What is the current status of trial NCT03914599?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2019-04-15. Estimated completion is 2022-07-11.
Who is sponsoring clinical trial NCT03914599?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.